Unresectable hepatocellular carcinoma (HCC) is rarely an isolated oncologic condition. In patients with cirrhosis, tumor control and hepatic reserve are inextricably intertwined, with portal hypertension (PH) potentially shaping both the safe delivery of systemic therapy and the magnitude of its clinical benefit.
No takes yet. Share an insight, caveat, or question.
Vozza et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: